Sasamoto, Yuzuru
Kiritoshi, Shoko
Lee, Catherine A. A.
Fukuda, Yoshiko
Martin, Gabrielle
Ksander, Bruce R.
Frank, Markus H.
Frank, Natasha Y.
Funding for this research was provided by:
NIH
Japan Eye Bank Association Overseas Award
Massachusetts Lions Eye Research Fund
Article History
Received: 21 June 2024
Accepted: 25 November 2024
First Online: 24 February 2025
Competing interests
: M.H.F., B.R.K. and N.Y.F. are inventors or co-inventors of US and international patents assigned to Brigham and Women’s Hospital, Boston Children’s Hospital, the Massachusetts Eye and Ear Infirmary and the VA Boston Healthcare System, Boston, MA, licensed to Rheacell GmbH & CoKG (Heidelberg, Germany). M.H.F. holds equity in and serves as a scientific advisor for Rheacell GmbH & CoKG. Y.S., S. K., C.A. A. L., Y. F., G. M. declare no competing interests.
: All methods were carried out in accordance with relevant guidelines and regulations.All experimental protocols were approved by the Brigham and Women’s Hospital Institutional Review Board committee.